Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells
- 14 March 2007
- journal article
- Published by Wiley in Cancer Science
- Vol. 98 (5) , 692-697
- https://doi.org/10.1111/j.1349-7006.2007.00446.x
Abstract
Zinc is an essential element, necessary for sustaining all life. Zinc deficiency causes taste impairments, immune deficiency, skin problems, and growth and mental retardation. Recent reports suggest that zinc is associated with an increased risk of cancer, although it is still unclear whether zinc or its transporters are involved in cancer progression. Here we show that zinc and its transporter ZIP10 are involved in the invasive behavior of breast cancer cells. The screening of clinical samples for ZIP10 mRNA expression suggested that ZIP10 was significantly associated with the metastasis of breast cancer to the lymph node. In addition, the expression of ZIP10 mRNA was higher in the invasive and metastatic breast cancer cell lines MDA‐MB‐231 and MDA‐MB‐435S than in less metastatic breast cancer cell lines, such as MCF7, T47D, ZR75‐1 and ZR75‐30. In in vitro cell migration assays, the depletion of zinc transporter ZIP10 and intracellular zinc inhibited the migratory activity of MDA‐MB‐231 and MDA‐MB‐435S cells. These results showed that zinc and ZIP10 play an essential role in the migratory activity of highly metastatic breast cancer cells, and suggest ZIP10 as a possible marker for the metastatic phenotype of breast cancer and a promising target of novel treatment strategies. (Cancer Sci 2007; 98: 692–697)This publication has 24 references indexed in Scilit:
- Molecular cloning and functional characterization of novel zinc transporter rZip10 (Slc39a10) involved in zinc uptake across rat renal brush-border membraneAmerican Journal of Physiology-Renal Physiology, 2007
- Toll-like receptor–mediated regulation of zinc homeostasis influences dendritic cell functionNature Immunology, 2006
- Copper, zinc, and Cu/Zn ratio in carcinoma of the gallbladderJournal of Surgical Oncology, 2005
- Expression levels of the putative zinc transporter LIV‐1 are associated with a better outcome of breast cancer patientsInternational Journal of Cancer, 2005
- MAMMALIAN ZINC TRANSPORTERSAnnual Review of Nutrition, 2004
- Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizerNature, 2004
- Oestrogen-regulated genes in breast cancer: Association of pLIV1 with lymph node involvementEuropean Journal Of Cancer, 1994
- Serum trace elements and Cu/Zn ratio in breast cancer patientsJournal of Surgical Oncology, 1991
- Zinc coordination, function, and structure of zinc enzymes and other proteinsBiochemistry, 1990
- Copper and Zinc levels in normal and malignant tissuesCancer, 1983